longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Aura Biosciences

AURA

6.0002.44% ( -0.150 )
Closed: Sep 25, 16:00:00 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -4.75, within the reasonable range, cheaper than 57.02% of the time in the past 3 years, and the industry ranks 367/603, the industry Median -2.26.

-4.75xP/E
$6.00Stock price
$-1.26Earnings per share
-4.75xP/E
Stock price$6.00Earnings per share$-1.26

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-4.61x
Typical range
-5.63x–-3.79x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
019385776

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
GILDUSGilead Sciences
-57.76x148.77%$187.15B
MRNAUSModerna
-25.20x15.47%$79.40B
CSLLYUSCSL Limited
-23.15x--$59.71B
NTRAUSNatera
-309.17x10.38%$59.47B
RVMDUSRevolution Medicines
-24.84x63.53%$43.93B
ROIVUSRoivant Sciences
-97.12x146.49%$25.86B
INSMUSInsmed
-29.40x74.62%$25.73B
BNTXUSBioNTech SE
-12.64x17.57%$24.75B
BBIOUSBridgebio Pharma
-18.53x28.57%$12.82B
SMMTUSSummit Therapeutics
-14.55x20.08%$12.45B
TWSTUSTwist Bioscience
-88.04x24.61%$12.04B
MDGLUSMadrigal Pharma
-36.71x51.07%$11.93B
ARWRUSArrowHead Pharma
-29.10x36,308.30%$9.31B
KYMRUSKymera Therapeutics
-31.07x4.94%$9.31B
CYTKUSCytokinetics
-10.06x6.37%$8.99B
IBRXUSImmunityBio
-9.01x152.63%$8.95B
PCVXUSVaxcyte
-7.86x48.80%$8.36B
ABVXUSAbivax SA
-17.04x20.94%$7.94B
PRAXUSPraxis Precision Medicines
-23.12x3.05%$7.84B
SYREUSSpyre Therapeutics
-50.30x47.81%$7.56B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.